Acute and latent viral infections in immunocompromised patients: a tale of brave battles and menacing foes

Affiliations

¹ University of Texas MD Anderson, Department of Infectious Diseases, Infection Control and Employee Health, Houston, TX, USA.
² University of Texas MD Anderson, Department of Infectious Diseases, Infection Control and Employee Health, Houston, TX, USA. Electronic address: rfchemaly@mdanderson.org.

Editorial

Amy Spallone et al. Clin Microbiol Infect. 2022 Oct.

. 2022 Oct;28(10):1319-1320.

doi: 10.1016/j.cmi.2022.06.010. Epub 2022 Jun 17.

¹ University of Texas MD Anderson, Department of Infectious Diseases, Infection Control and Employee Health, Houston, TX, USA.
² University of Texas MD Anderson, Department of Infectious Diseases, Infection Control and Employee Health, Houston, TX, USA. Electronic address: rfchemaly@mdanderson.org.

No abstract available

Comment on

1. El Haddad L., Ariza-Heredia E., Shah D.P., Jiang Y., Blanchard T., Ghantoji S.S., et al. The ability of a cytomegalovirus ELISPOT assay to predict outcome of low-level CMV reactivation in hematopoietic cell transplant recipients. J Infect Dis. 2019;219(23):898–907. - PMC - PubMed
1. Yamamoto Y., Shiroyama T., Hirata H., Kuge T., Matsumoto K., Yoneda M., et al. Prolonged corticosteroid therapy and cytomegalovirus infection in patients with severe COVID-19. J Med Virol. 2022;94:1067–1073. - PMC - PubMed
1. Hwang J.P., Feld J.J., Hammond S.P., Wang S.H., Alston-Johnson D.E., Cryer D.R., et al. Hepatitis B virus screening and management for patients with cancer prior to therapy: ASCO provisional clinical opinion update. J Clin Oncol. 2020;38:3698–3715. - PMC - PubMed